07 Aug, 2026

New Nabla CEO explains how to gain market share in an AI scribe environment

Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits or could be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon and Bluesky. You can reach Brittany on Signal at btrang.01. Nabla, the Paris-based manufacturer of ambient scribes used to automate clinical documentation, claims to […]

3 mins read

New AI sepsis detection models challenge Epic’s market position

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy, with a focus on the impacts of digital healthcare for patients, providers, and businesses. You can reach Katie on Signal at palmer.01. You are reading the second part of Paying for AI, a series examining how new artificial intelligence clinical tools are influencing […]

3 mins read